Alclometasone |
Aclovate |
Article: Alclometasone
![]() | |
| Alclometasone | |
| Systematic (IUPAC) name | |
| [7-chloro-11-hydroxy- 10,13,16-trimethyl-3-oxo-17- (2-propanoyloxyacetyl)- 7,8,9,11,12, 14,15,16- octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate | |
| Identifiers | |
| CAS number | 66734-13-2 |
| ATC code | D07AB10 S01BA10 |
| PubChem | 636374 |
| DrugBank | APRD00783 |
| Chemical data | |
| Formula | C28H37ClO7 |
| Mol. weight | 521.042 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | topical |
Alclometasone is a synthetic glucocorticoid steroid, available in cream or ointment form, for topical dermatologic use. It is marketed in the United States as Aclovate by GlaxoSmithKline.
Categories: Pharmacology stubs | Glucocorticoids

Not Signed In - 


